Next Article in Journal
Design, Radiosynthesis and Preliminary Biological Evaluation in Mice of a Brain-Penetrant 18F-Labelled σ2 Receptor Ligand
Next Article in Special Issue
Impaired Leptin Signalling in Obesity: Is Leptin a New Thermolipokine?
Previous Article in Journal
Selective Inhibition of PDE4B Reduces Binge Drinking in Two C57BL/6 Substrains
Previous Article in Special Issue
Is LRP2 Involved in Leptin Transport over the Blood-Brain Barrier and Development of Obesity?
Review

Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells

by 1,2,* and 1,2
1
Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH 44272, USA
2
School of Biomedical Sciences, Kent State University, Kent, OH 44240, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Susan Kralisch
Int. J. Mol. Sci. 2021, 22(11), 5446; https://doi.org/10.3390/ijms22115446
Received: 15 April 2021 / Revised: 11 May 2021 / Accepted: 17 May 2021 / Published: 21 May 2021
(This article belongs to the Special Issue Leptin–Metabolic Programming and Its Endocrine Signals)
Increasing adipose tissue mass in obesity directly correlates with elevated circulating leptin levels. Leptin is an adipokine known to play a role in numerous biological processes including regulation of energy homeostasis, inflammation, vascular function and angiogenesis. While physiological concentrations of leptin may exhibit multiple beneficial effects, chronically elevated pathophysiological levels or hyperleptinemia, characteristic of obesity and diabetes, is a major risk factor for development of atherosclerosis. Hyperleptinemia results in a state of selective leptin resistance such that while beneficial metabolic effects of leptin are dampened, deleterious vascular effects of leptin are conserved attributing to vascular dysfunction. Leptin exerts potent proatherogenic effects on multiple vascular cell types including macrophages, endothelial cells and smooth muscle cells; these effects are mediated via an interaction of leptin with the long form of leptin receptor, abundantly expressed in atherosclerotic plaques. This review provides a summary of recent in vivo and in vitro studies that highlight a role of leptin in the pathogenesis of atherosclerotic complications associated with obesity and diabetes. View Full-Text
Keywords: hyperleptinemia; endothelial cells; vascular smooth muscle cells; macrophages; atherosclerosis hyperleptinemia; endothelial cells; vascular smooth muscle cells; macrophages; atherosclerosis
Show Figures

Figure 1

MDPI and ACS Style

Raman, P.; Khanal, S. Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells. Int. J. Mol. Sci. 2021, 22, 5446. https://doi.org/10.3390/ijms22115446

AMA Style

Raman P, Khanal S. Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells. International Journal of Molecular Sciences. 2021; 22(11):5446. https://doi.org/10.3390/ijms22115446

Chicago/Turabian Style

Raman, Priya, and Saugat Khanal. 2021. "Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells" International Journal of Molecular Sciences 22, no. 11: 5446. https://doi.org/10.3390/ijms22115446

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop